About the Study

Yellow fever is a viral infection spread by mosquitos, most commonly found in tropical and subtropical areas of South America and Africa. Worldwide, around 600 million people live in endemic areas for Yellow fever. The World Health Organization estimates 200,000 cases of Yellow fever per year and an estimated 30,000 deaths caused by Yellow fever annually. There is currently no medicine to treat or cure Yellow fever infection.

The purpose of this study is to assess the immune response of the investigational vaccine as compared to the currently approved Yellow Fever vaccine.  The study will last approximately 5 years with 10 visits to our office.

Study-related care is available to participants at no cost and health insurance is not required nor needed. Compensation for time and travel is available up to $875 to those who qualify.

Qualifications

  • Be between the ages of 18 and 60 years old
  • No previous diagnosis of Yellow Fever
  • Have not previously received a Yellow Fever vaccine
  • *Please note, other conditions may apply